Topic 421 (phase II): biomimetic optical phantoms for advancing FGS

Ended Definitive Contract Awarded Last action

Contract number
75N91023C00052
Awardee
Awarding agency
Obligated
$1,999,785

Award facts

Contract value 100% obligated
$1,999,785.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
White River Junction, Hartford, VT, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $1,999,785

About this award

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $2 million definitive contract to Quel Imaging, LLC for TOPIC 421 (PHASE II): BIOMIMETIC OPTICAL PHANTOMS FOR ADVANCING FGS. The contract is a firm fixed price agreement with a two-year period of performance from September 2023 through September 2025 in White River Junction, Vermont. Quel Imaging, LLC will provide biomimetic optical phantoms to advance fluorescence guided surgery as the total small business set aside was awarded.

Quick answers

Who was awarded contract 75N91023C00052?

75N91023C00052 was awarded to Quel Imaging, LLC by National Cancer Institute (National Institutes of Health) on September 5, 2023.

How much is contract 75N91023C00052 worth?

The government has obligated $1,999,785 on 75N91023C00052.

Was contract 75N91023C00052 competed?

The extent of competition for 75N91023C00052 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award